MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy
Fabricio de Carvalho, Veruska L. F. Alves, Walter M. T. Braga, Celso V. Xavier Jr., Gisele W. B. ColleoniVolume:
62
Language:
english
DOI:
10.1007/s00262-012-1376-4
Date:
January, 2013
File:
PDF, 233 KB
english, 2013